832 related articles for article (PubMed ID: 19765775)
1. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
Chang YC; Chang TJ; Lee WJ; Chuang LM
Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats.
Sun Q; Li L; Li R; Yang M; Liu H; Nowicki MJ; Zong H; Xu J; Yang G
Ann Med; 2009; 41(4):311-20. PubMed ID: 19263259
[TBL] [Abstract][Full Text] [Related]
3. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
[TBL] [Abstract][Full Text] [Related]
4. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease.
Moschen AR; Geiger S; Gerner R; Tilg H
Mutat Res; 2010 Aug; 690(1-2):95-101. PubMed ID: 19583971
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
6. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
7. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine.
Sommer G; Garten A; Petzold S; Beck-Sickinger AG; Blüher M; Stumvoll M; Fasshauer M
Clin Sci (Lond); 2008 Jul; 115(1):13-23. PubMed ID: 19016657
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
9. Visfatin and its role in obesity development.
Stastny J; Bienertova-Vasku J; Vasku A
Diabetes Metab Syndr; 2012; 6(2):120-4. PubMed ID: 23153983
[TBL] [Abstract][Full Text] [Related]
10. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.
Pagano C; Pilon C; Olivieri M; Mason P; Fabris R; Serra R; Milan G; Rossato M; Federspil G; Vettor R
J Clin Endocrinol Metab; 2006 Aug; 91(8):3165-70. PubMed ID: 16720654
[TBL] [Abstract][Full Text] [Related]
11. The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects.
Johansson LM; Johansson LE; Ridderstråle M
Metabolism; 2008 Nov; 57(11):1558-62. PubMed ID: 18940394
[TBL] [Abstract][Full Text] [Related]
12. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities.
Brentano F; Schorr O; Ospelt C; Stanczyk J; Gay RE; Gay S; Kyburz D
Arthritis Rheum; 2007 Sep; 56(9):2829-39. PubMed ID: 17763446
[TBL] [Abstract][Full Text] [Related]
13. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
[TBL] [Abstract][Full Text] [Related]
14. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile.
Wang P; van Greevenbroek MM; Bouwman FG; Brouwers MC; van der Kallen CJ; Smit E; Keijer J; Mariman EC
Pflugers Arch; 2007 Sep; 454(6):971-6. PubMed ID: 17429683
[TBL] [Abstract][Full Text] [Related]
15. Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise.
Frydelund-Larsen L; Akerstrom T; Nielsen S; Keller P; Keller C; Pedersen BK
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E24-31. PubMed ID: 16868228
[TBL] [Abstract][Full Text] [Related]
16. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
17. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
Tilg H; Moschen AR
Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
[TBL] [Abstract][Full Text] [Related]
18. Effects of visfatin/PBEF/NAMPT on feeding behaviour and hypothalamic neuromodulators in the rat.
Brunetti L; Recinella L; Di Nisio C; Chiavaroli A; Leone S; Ferrante C; Orlando G; Vacca M
J Biol Regul Homeost Agents; 2012; 26(2):295-302. PubMed ID: 22824756
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.
Araki S; Dobashi K; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Asayama K; Shirahata A
Obesity (Silver Spring); 2008 Feb; 16(2):384-8. PubMed ID: 18239648
[TBL] [Abstract][Full Text] [Related]
20. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines.
Terra X; Auguet T; Quesada I; Aguilar C; Luna AM; Hernández M; Sabench F; Porras JA; Martínez S; Lucas A; Pellitero S; Llutart J; del Castillo D; Richart C
Clin Endocrinol (Oxf); 2012 Nov; 77(5):691-8. PubMed ID: 22182404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
